Journal of Marine Medical Society

ORIGINAL ARTICLE
Year
: 2021  |  Volume : 23  |  Issue : 1  |  Page : 47--51

Selenium abrogates tenofovir/lamivudine/efavirenz-induced hepatotoxicity in rats


Elias Adikwu1, Michael Ikechukwu Oraebosi2, Innocent Biradee3 
1 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Niger Delta University, Bayelsa State, Nigeria
2 Department of Pharmacology and Therapeutics, Nile University of Nigeria, Abuja, Nigeria
3 Department of Biomedical Technology, School of Science Laboratory Technology, University of Port Harcourt, Rivers State, Nigeria

Correspondence Address:
(Dr) Elias Adikwu
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Niger Delta University, Bayelsa State
Nigeria

Background: The therapeutic benefit of tenofovir/lamivudine/efavirenz (TLE) in the treatment of human immunodeficiency virus can be truncated by the occurrence of hepatotoxicity. This study evaluated the protective effect of selenium (Se) against hepatotoxicity induced by TLE in albino rats. Materials and Methods: Adult male albino rats (n = 40) randomized into four groups (n = 10) were used. Group 1 (Control) orally received normal saline (0.2 mL) daily. Group 2 orally received Se (0.1 mg/kg) daily. Group 3 orally received TLE (8.6/8.6/17.1 mg/kg) daily. Group 4 orally received Se (0.1 mg/kg) and TLE (8.6/8.6/17.1 mg/kg) daily. All rats were treated for 90 days. After treatment, the rats were euthanized, and serum samples were centrifuged from blood samples and assessed for liver function markers. Liver samples were harvested and evaluated for morphological changes and biochemical parameters. Results: Impaired liver redox status in TLE-treated rats was characterized by remarkable (P < 0.001) decreases in glutathione peroxidase superoxide dismutase, catalase, and glutathione levels with remarkable (P < 0.001) increases in malondialdehyde levels when compared to control. The alterations in liver function markers were marked by remarkable (P < 0.001) increases in serum aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, alkaline phosphatase, gamma-glutamyl transferase, conjugated bilirubin and total bilirubin levels when compared to control. Hepatocyte necrosis and fatty change were observed in TLE-treated rats. However, TLE-induced hepatotoxic changes were significantly (P < 0.01) reversed in Se supplemented rats when compared to TLE. Conclusion: Se may be clinically effective against hepatotoxicity caused by TLE.


How to cite this article:
Adikwu E, Oraebosi MI, Biradee I. Selenium abrogates tenofovir/lamivudine/efavirenz-induced hepatotoxicity in rats.J Mar Med Soc 2021;23:47-51


How to cite this URL:
Adikwu E, Oraebosi MI, Biradee I. Selenium abrogates tenofovir/lamivudine/efavirenz-induced hepatotoxicity in rats. J Mar Med Soc [serial online] 2021 [cited 2021 Dec 4 ];23:47-51
Available from: https://www.marinemedicalsociety.in/article.asp?issn=0975-3605;year=2021;volume=23;issue=1;spage=47;epage=51;aulast=Adikwu;type=0